Forget lung, breast or prostate cancer: why tumour naming needs to change

被引：38

作者：

Andre, Fabrice ^{[1
,2
,3
]}

Rassy, Elie ^{[4
,5
,6
]}

Marabelle, Aurelien ^{[2
,7
,8
]}

Michiels, Stefan ^{[5
,6
]}

Besse, Benjamin ^{[1
,2
,3
]}

机构：

[1] Gustave Roussy, Dept Oncol Med, Res Div, Villejuif, France

[2] Paris Saclay Univ, Fac Med, Le Kremlin Bicetre, France

[3] Natl Inst Hlth & Med Res INSERM, U981, Villejuif, France

[4] Gustave Roussy, Dept Oncol Med, Villejuif, France

[5] Gustave Roussy, Biostat & Epidemiol Off, Clin Res Div, Villejuif, France

[6] Paris Saclay Univ, Natl Inst Hlth & Med Res INSERM 9, U1018, CESP, Villejuif, France

[7] Gustave Roussy, Dept Therapeut Innovat & Early Trials, Villejuif, France

[8] Natl Inst Hlth & Med Res INSERM, CIC1428, Villejuif, France

来源：

NATURE | 2024年 / 626卷 / 7997期

关键词：

Cancer; Drug discovery; Medical research; Health care;

D O I：

10.1038/d41586-024-00216-3

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The conventional way of classifying metastatic cancers according to their organ of origin is denying people access to drugs that could help them.

引用

页码：26 / 29

页数：4

共 15 条

[1] Considering molecular alterations as pan-cancer tissue-agnostic targets [J].

Adashek, Jacob J. ;

Kato, Shumei ;

Sicklick, Jason K. ;

Lippman, Scott M. ;

Kurzrock, Razelle .

NATURE CANCER, 2023, 4 (12) :1622-1626

[2] Genomics to select treatment for patients with metastatic breast cancer [J].

Andre, Fabrice ;

Filleron, Thomas ;

Kamal, Maud ;

Mosele, Fernanda ;

Arnedos, Monica ;

Dalenc, Florence ;

Sablin, Marie-Paule ;

Campone, Mario ;

Bonnefoi, Herve ;

Lefeuvre-Plesse, Claudia ;

Jacot, William ;

Coussy, Florence ;

Ferrero, Jean-Marc ;

Emile, George ;

Mouret-Reynier, Marie-Ange ;

Thery, Jean-Christophe ;

Isambert, Nicolas ;

Mege, Alice ;

Barthelemy, Philippe ;

You, Benoit ;

Hajjaji, Nawale ;

Lacroix, Ludovic ;

Rouleau, Etienne ;

Tran-Dien, Alicia ;

Boyault, Sandrine ;

Attignon, Valery ;

Gestraud, Pierre ;

Servant, Nicolas ;

Le Tourneau, Christophe ;

Cherif, Linda Larbi ;

Soubeyran, Isabelle ;

Montemurro, Filippo ;

Morel, Alain ;

Lusque, Amelie ;

Jimenez, Marta ;

Jacquet, Alexandra ;

Goncalves, Anthony ;

Bachelot, Thomas ;

Bieche, Ivan .

NATURE, 2022, 610 (7931) :343-+

[3]

Behera M, 2022, J CLIN ONCOL, V40

[4] Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis [J].

Demonceau, Jenny ;

Ruppar, Todd ;

Kristanto, Paulus ;

Hughes, Dyfrig A. ;

Fargher, Emily ;

Kardas, Przemyslaw ;

De Geest, Sabina ;

Dobbels, Fabienne ;

Lewek, Pawel ;

Urquhart, John ;

Vrijens, Bernard .

DRUGS, 2013, 73 (06) :545-562

[5] Are 90% of deaths from cancer caused by metastases? [J].

Dillekas, Hanna ;

Rogers, Michael S. ;

Straume, Oddhjorn .

CANCER MEDICINE, 2019, 8 (12) :5574-5576

[6]

Gill J., 2020, ACCESS PERSONALISED, DOI [10.21953/lse.5zsbeehvd3u8, DOI 10.21953/LSE.5ZSBEEHVD3U8]

[7] The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[8] Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [J].

Hendriks, L. E. ;

Kerr, K. M. ;

Menis, J. ;

Mok, T. S. ;

Nestle, U. ;

Passaro, A. ;

Peters, S. ;

Planchard, D. ;

Smit, E. F. ;

Solomon, B. J. ;

Veronesi, G. ;

Reck, M. .

ANNALS OF ONCOLOGY, 2023, 34 (04) :339-357

[9] Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer [J].

Kather, Jakob Nikolas ;

Pearson, Alexander T. ;

Halama, Niels ;

Jaeger, Dirk ;

Krause, Jeremias ;

Loosen, Sven H. ;

Marx, Alexander ;

Boor, Peter ;

Tacke, Frank ;

Neumann, Ulf Peter ;

Grabsch, Heike I. ;

Yoshikawa, Takaki ;

Brenner, Hermann ;

Chang-Claude, Jenny ;

Hoffmeister, Michael ;

Trautwein, Christian ;

Luedde, Tom .

NATURE MEDICINE, 2019, 25 (07) :1054-+

[10] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer [J].

Kopetz, S. ;

Grothey, A. ;

Yaeger, R. ;

Van Cutsem, E. ;

Desai, J. ;

Yoshino, T. ;

Wasan, H. ;

Ciardiello, F. ;

Loupakis, F. ;

Hong, Y. S. ;

Steeghs, N. ;

Guren, T. K. ;

Arkenau, H. -T. ;

Garcia-Alfonso, P. ;

Pfeiffer, P. ;

Orlov, S. ;

Lonardi, S. ;

Elez, E. ;

Kim, T. -W. ;

Schellens, J. H. M. ;

Guo, C. ;

Krishnan, A. ;

Dekervel, J. ;

Morris, V. ;

Calvo Ferrandiz, A. ;

Tarpgaard, L. S. ;

Braun, M. ;

Gollerkeri, A. ;

Keir, C. ;

Maharry, K. ;

Pickard, M. ;

Christy-Bittel, J. ;

Anderson, L. ;

Sandor, V. ;

Tabernero, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17) :1632-1643

← 1 2 →